 Patients receive vaccinia-NY-ESO-1 vaccine intradermally on day 1 and fowlpox-NY-ESO-1 vaccine subcutaneously on days 29, 57, 85, 113, 141, and 169 in the absence of disease progression or unacceptable toxicity. 